首页> 外国专利> METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME

METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME

机译:实时与华侨城对八八管控制中央视网膜静脉闭塞相关治疗黄斑水肿的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to ophthalmology. Treatment is carried out within one month from the moment of occlusion. At the first stage, a subthreshold micropulse laser exposure (SMILV) with a wavelength of 810 nm, low intensity or high density is carried out. Then, a panmacular operation is carried out 500 microns from the center of the macula, and an expanded paramacular operation is carried out in the upper or lower hemisphere, respectively, of the localization of the occluded branch of the CRV not reaching 500 microns to the optic disc and vascular arcade. In this case, the application of the applicates is carried out by the drain method without intervals, sector-by-sector, according to the "painting" technique, using subthreshold testing with OCT-dosimetric control in real time. At the second stage, after 50-60 minutes intravitreal administration of a VEGF inhibitor is performed. Repeated courses of complex treatment are carried out in 1.5-2 months or more. ;EFFECT: method makes it possible to treat macular edema in the early period from the moment of occlusion to the development of irreversible structural and functional disorders, allows to shorten the treatment time, to obtain an earlier, stable and effective restoration of the anatomy of the macula and visual functions; reduce the number of intravitreal injections of a VEGF inhibitor required.;1 cl, 2 ex
机译:田地:药物。物质:发明涉及药物,即眼科。从闭塞时期的一个月内进行治疗。在第一阶段,进行波长为810nm,强度或高密度的亚阈值微型激光曝光(Smilv)。然后,从黄斑的中心进行平坦操作500微米,并且分别在上半球的遮挡分支的定位中进行扩展的调节操作,而不是达到500微米的封闭支线光盘和血管拱廊。在这种情况下,根据“绘画”技术,通过逐个扇区的漏极方法进行漏油方法进行漏油方法,使用亚阈值测试实时使用OCT-Dosimetric控制。在第二阶段,进行50-60分钟后进行VEGF抑制剂。重复的复杂治疗疗程在1.5-2个月或更长时间内进行。 ;效果:方法使得可以在从闭塞到不可逆结构和功能障碍的发育的早期治疗黄斑水肿,允许缩短治疗时间,以获得早期,稳定有效的解剖学恢复黄斑和视觉功能;减少所需VEGF抑制剂的玻璃体内注射次数。; 1 CL,2 EX

著录项

  • 公开/公告号RU2749122C1

    专利类型

  • 公开/公告日2021-06-04

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20190140975

  • 申请日2019-12-10

  • 分类号A61F9;A61F9/008;

  • 国家 RU

  • 入库时间 2022-08-24 19:13:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号